Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $3.9660, but opened at $3.7930. Raia Drogasil shares last traded at $3.7930, with a volume of 1,173,000 shares.
Raia Drogasil Stock Down 1.7%
The business has a fifty day moving average of $3.57 and a 200 day moving average of $4.22.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.05. The company had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. On average, equities analysts expect that Raia Drogasil S.A. will post 0.16 EPS for the current fiscal year.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Stories
- Five stocks we like better than Raia Drogasil
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
